Magnolia Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Magnolia Capital Advisors's MRK Position: Q2 2026 in Review
Magnolia Capital Advisors reduced its Merck (MRK) stake by 0.25% in Q2 2026, selling an estimated $10.1K and leaving 34,718 shares worth $4.46M. The position accounts for 0.77% of the portfolio, ranked #39.
Magnolia Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Magnolia Capital Advisors held 34,718 shares of Merck worth $4.46M as of Q2 2026.
- Magnolia Capital Advisors sold 86 Merck shares in Q2 2026, an estimated $10.1K.
- Merck made up 0.77% of Magnolia Capital Advisors's portfolio in Q2 2026, its #39 holding.
- Magnolia Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
- 3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.